Two COVID-19 vaccine products for young children are nearing the final stages of the Emergency Use Authorization (EUA) process. Pfizer-BioNTech is submitting data on a THREE-dose primary series for a vaccine for children ages six months through FOUR years of age (6m–4y). Moderna is submitting data on a TWO-dose primary series for children ages six months through FIVE years of age (6m–5 y). The authorization is a multi-step clinical and regulatory process, and no vaccine can be administered until the final recommendation is issued by the CDC Director, Dr. Walensky. In preparation, this guidance includes details about BOTH products.
Search
Recent Posts
See AllMONDAY, JULY 25, 2022 11:30 AM – 1 PM ET Our Summer Academy involves a diverse group of students from various educational backgrounds spanning from high school, college, undergraduate medical educatio
Albany, NY - July 5, 2022—The New York State HPV Coalition, the NYS Department of Health and the NYC Department of Health and Mental Hygiene are united in their commitment to eliminating preventable
“Today’s Supreme Court decision to overturn Roe v. Wade means that the once Constitutionally protected right to access an abortion is no longer guaranteed nationwide. This decision carries grave conse